These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4726928)

  • 1. Possible role of hormones in treatment of metastatic testicular teratomas: tumour regression with medroxyprogesterone acetate.
    Bloom HJ; Hendry WF
    Br Med J; 1973 Sep; 3(5880):563-7. PubMed ID: 4726928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of breast cancer with medroxyprogesterone acetate.
    Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
    Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose medroxyprogesterone acetate (MPA) treatment in metastatic carcinoma of the breast: a dose-response evaluation.
    Cuna GR; Calciati A; Strada MR; Bumma C; Campio L
    Tumori; 1978 Apr; 64(2):143-9. PubMed ID: 354147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose medroxyprogesterone acetate (MPA) treatment in advanced breast cancer. A review.
    Ganzina F
    Tumori; 1979 Oct; 65(5):563-85. PubMed ID: 390798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The surgical management of testis tumors metastatic to the lung: a report of 10 cases with subsequent resection of from one to seven pulmonary metastases.
    Skinner DG; Leadbetter WF; Wilkins EW
    J Urol; 1971 Feb; 105(2):275-82. PubMed ID: 4103809
    [No Abstract]   [Full Text] [Related]  

  • 8. [Actinomycin-D therapy in testicular cancer (author's transl)].
    Höffken K; Tingelhoff J; Seeber S; Schmidt CG
    Urologe A; 1976 Mar; 15(2):61-6. PubMed ID: 1265932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single agent chemotherapy (actinomycin D) in the treatment of metastatic testicular carcinoma.
    Early KS; Albert DJ
    South Med J; 1976 Aug; 69(8):1017-21. PubMed ID: 986690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for metastatic teratomas of the testis.
    Smithers DW
    Br J Urol; 1972 Apr; 44(2):217-28. PubMed ID: 4261216
    [No Abstract]   [Full Text] [Related]  

  • 11. Metastases to skin from occult malignant neoplasms. Cutaneous metastases from a teratocarcinoma.
    Price NM; Kopf AW
    Arch Dermatol; 1974 Apr; 109(4):547-50. PubMed ID: 4819111
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastatic embryonal cell carcinoma of testis: an apparent 8-year cure.
    Dees JE
    J Urol; 1973 Jul; 110(1):90-2. PubMed ID: 4713368
    [No Abstract]   [Full Text] [Related]  

  • 13. Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes.
    Albrecht BH; Schiff I; Tulchinsky D; Ryan KJ
    Am J Obstet Gynecol; 1981 Mar; 139(6):631-5. PubMed ID: 7211966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
    Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
    J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grwoth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate.
    Concannon P; Altszuler N; Hampshire J; Butler WR; Hansel W
    Endocrinology; 1980 Apr; 106(4):1173-7. PubMed ID: 6444575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.
    Calaminus G; Schneider DT; Weissbach L; Schönberger S; Okpanyi V; Leuschner I; Poremba C; Göbel U
    Klin Padiatr; 2009; 221(3):136-40. PubMed ID: 19437360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy of germ cell tumors of the testis with vincristine, adriamycin, cyclophosphamide, actinomycin D and medroxyprogesterone acetate.
    Klepp O; Klepp R; Host H; Asbjornsen G; Talle K; Stenwig AE
    Cancer; 1977 Aug; 40(2):638-46. PubMed ID: 70266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secretion in idiopathic precocious puberty: effect of medroxyprogesterone.
    Kaplan S; Frasier SD; Costin G
    J Pediatr; 1969 Jul; 75(1):133-8. PubMed ID: 5790396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of gonadal protection by medroxyprogesterone acetate-induced transient medical castration during chemotherapy for testicular cancer.
    Fosså SD; Klepp O; Norman N
    Br J Urol; 1988 Nov; 62(5):449-53. PubMed ID: 2850071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.